2seventy bio, Inc. (TSVT)
(Delayed Data from NSDQ)
$2.61 USD
+0.17 (6.97%)
Updated Jan 17, 2025 04:00 PM ET
After-Market: $2.61 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
C Value B Growth D Momentum B VGM
2seventy bio, Inc. (TSVT) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$8.00 | $12.00 | $2.00 | 206.51% |
Find the top stocks with the greatest target price potential and Zacks Rank of 1 or 2
Price Target
Based on short-term price targets offered by five analysts, the average price target for 2seventy bio, Inc. comes to $8.00. The forecasts range from a low of $2.00 to a high of $12.00. The average price target represents an increase of 206.51% from the last closing price of $2.61.
Analyst Price Targets (5 )
Broker Rating
2seventy bio, Inc. currently has an average brokerage recommendation (ABR) of 2.43 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by seven brokerage firms. The current ABR compares to an ABR of 2.43 a month ago based on seven recommendations.
Of the seven recommendations deriving the current ABR, three are Strong Buy, representing 42.86% of all recommendations. A month ago, Strong Buy represented 42.86%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 3 | 3 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 2.43 | 2.43 | 2.43 | 2.43 | 2.43 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
10/22/2024 | Cowen & Co. | Yaron Werber | Hold | Hold |
9/26/2024 | SVB Securities | Daina M Graybosch | Strong Buy | Strong Buy |
6/18/2024 | Guggenheim Securities | Kelsey Goodwin | Hold | Hold |
6/6/2024 | Goldman Sachs | Salveen Richter | Hold | Strong Sell |
5/9/2024 | Canaccord Genuity | John L Newman | Not Available | Strong Buy |
4/8/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.43 |
ABR (Last week) | 2.43 |
# of Recs in ABR | 7 |
Average Target Price | $8.00 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 66 of 251 |
Current Quarter EPS Est: | -0.20 |
TSVT FAQs
2seventy bio, Inc. (TSVT) currently has an average brokerage recommendation (ABR) of 2.43 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 7 brokerage firms.
The average price target for 2seventy bio, Inc. (TSVT) is $8.00. The current on short-term price targets is based on 5 reports.
The forecasts for 2seventy bio, Inc. (TSVT) range from a low of $2 to a high of $12. The average price target represents a increase of $206.51 from the last closing price of $2.61.
The current UPSIDE for 2seventy bio, Inc. (TSVT) is 206.51%
Based on short-term price targets offered by five analysts, the average price target for 2seventy bio, Inc. comes to $8.00. The forecasts range from a low of $2.00 to a high of $12.00. The average price target represents an increase of 206.51% from the last closing price of $2.61.